- Home
- MAX vs ORIC Comparison
MAX vs ORIC Comparison
Compare MAX & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAX
- ORIC
- Stock Information
- Founded
- MAX 2014
- ORIC 2014
- Country
- MAX United States
- ORIC United States
- Employees
- MAX N/A
- ORIC N/A
- Industry
- MAX Industrial Machinery/Components
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MAX Industrials
- ORIC Health Care
- Exchange
- MAX Nasdaq
- ORIC Nasdaq
- Market Cap
- MAX 604.9M
- ORIC 735.3M
- IPO Year
- MAX 2020
- ORIC 2020
- Fundamental
- Price
- MAX $11.77
- ORIC $10.84
- Analyst Decision
- MAX Buy
- ORIC Strong Buy
- Analyst Count
- MAX 8
- ORIC 9
- Target Price
- MAX $22.00
- ORIC $18.75
- AVG Volume (30 Days)
- MAX 375.8K
- ORIC 825.1K
- Earning Date
- MAX 02-24-2025
- ORIC 03-10-2025
- Dividend Yield
- MAX N/A
- ORIC N/A
- EPS Growth
- MAX N/A
- ORIC N/A
- EPS
- MAX 0.19
- ORIC N/A
- Revenue
- MAX $681,230,000.00
- ORIC N/A
- Revenue This Year
- MAX $122.48
- ORIC N/A
- Revenue Next Year
- MAX $32.24
- ORIC N/A
- P/E Ratio
- MAX $62.34
- ORIC N/A
- Revenue Growth
- MAX 72.47
- ORIC N/A
- 52 Week Low
- MAX $10.21
- ORIC $6.33
- 52 Week High
- MAX $25.78
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- MAX 55.43
- ORIC 52.90
- Support Level
- MAX $11.02
- ORIC $9.92
- Resistance Level
- MAX $11.73
- ORIC $12.00
- Average True Range (ATR)
- MAX 0.45
- ORIC 0.90
- MACD
- MAX 0.09
- ORIC 0.04
- Stochastic Oscillator
- MAX 75.00
- ORIC 41.82
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.